Meeting
2014 ASCO Annual Meeting
Impact of long-term serum platinum on neuro- and ototoxicity, cardiovascular disease, and hypogonadism in testicular cancer survivors.
Authors
Line veronika Hjelle
Department of Oncology, Univesity Hospital of North Norway, Tromsø, Norway
Line veronika Hjelle , Roy M. Bremnes , per Ole Gundersen , Mette Sprauten , Marianne Brydoy , Torgrim Tandstad , Tom Wilsgaard , Sophie D. Fossa , Jan Oldenburg , Hege Sagstuen Haugnes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4518)
DOI
10.1200/jco.2014.32.15_suppl.4518
Abstract #
4518
Poster Bd #
10
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Testosterone (T), luteinizing hormone (LH), and follicle stimulating hormone (FSH) levels in testicular cancer survivors (TCSs) 11 and 19 years after orchiectomy.
First Author: Mette Sprauten
Poster
2022 ASCO Annual Meeting
Change in telomere length and cardiovascular risk in testicular cancer survivors.
First Author: Ellen L.D. Volders
Poster
2016 ASCO Annual Meeting
Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study.
First Author: Mohammad Issam Abu Zaid
Poster
2016 Cancer Survivorship Symposium
Cardiovascular disease (CVD) risk factors and health behaviors following cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS).
First Author: Mohammad Issam Abu Zaid